Test Result Flag Range Units WBC *3.8 L 4.5 10.5 /mm3 – RBC 3.98 3.69 5.13 /mm3 – Hemoglobin 14.0 11.7 14.5 g/dL – Hematocrit 38.9 34.1 44.3 % – MCV *97.8 H 80.6 95.8 U3 – MCH *35.1 H 27.1 33.1 pg – MCHC 35.9 32.2 36.7 % – RDW 12.1 10.3 12.9 % – Platelets 152 143 314 /mm3 – MPV *5.5 L 6.0 9.0 U3 – % 29.7 19.4 42.9 % – # *1.1 L 1.2 3.0 /mm3 – Gran: % 54.2 39.3 73.7 % – # 2.0 1.2 7.0 /mm3 – Mono: % 10.9 4.4 12.7 – # 0.4 0.2 0.8 % – Eos: % 1.6 0.6 7.3 – # 0.1 0.0 0.4 % – Baso: % *3.6 H 1.7 – # *0.1 H 0.0 0.1 % – Reflex YES 204.10 Manual Differential SEG manual 60 40-70 % Lymph manual 32 20-45 % Mono manual 8 2-10 % ANISO 1+ MACRO 1+ POIK 1+ Appendix C: Treatment Modalities/Considerations 1: Anti-viral agents considered to decrease length and severity of acute episode Agent: Acyclovir Famicyclovir Valacyclovir Foscarnet Dose: 800mg po po 1,000mg po 40mg/kg IV 4 hourly (mostly 8 hourly 8 hourly 8 hourly over 1 hour given 5 x/day) infusion 7-10 days 7 days 7 days 10 days Primary drug Pro-drug Pro-drug Pro-drug Inconvenience of Considered more Contra-indicated for Only available for IV frequent dosing helpful (than acyclovir) some administration requirement in prevention of PHN patients Reserved for cases Convenient dosing Convenient dosing resistant to acyclovir
Test Result Flag Range Units WBC *3.8 L 4.5 – 10.5 /mm3 RBC 3.98 3.69 – 5.13 /mm3 Hemoglobin 14.0 11.7 – 14.5 g/dL Hematocrit 38.9 34.1 – 44.3 % MCV *97.8 H 80.6 – 95.8 U3 MCH *35.1 H 27.1 – 33.1 pg MCHC 35.9 32.2 – 36.7 % RDW 12.1 10.3 – 12.9 % Platelets 152 143 – 314 /mm3 MPV *5.5 L 6.0 – 9.0 U3 % # 29.7 *1.1 L 19.4 – 42.9 1.2 – 3.0 % /mm3 Gran: % # 54.2 2.0 39.3 – 73.7 1.2 – 7.0 % /mm3 Mono: % # 10.9 0.4 4.4 – 12.7 0.2 – 0.8 % Eos: % # 1.6 0.1 0.6 – 7.3 0.0 – 0.4 % Baso: % # *3.6 *0.1 H H – 1.7 0.0 – 0.1 % Reflex YES 204.10 Manual Differential SEG manual 60 40-70 % Lymph manual 32 20-45 % Mono manual 8 2-10 % ANISO 1+ MACRO 1+ POIK 1+ Appendix C: Treatment Modalities/Considerations 1: Anti-viral agents considered to decrease length and severity of acute episode Agent: Acyclovir Famicyclovir Valacyclovir Foscarnet Dose: 800mg po 4 hourly (mostly given 5 x/day) 7-10 days po 8 hourly 7 days 1,000mg po 8 hourly 7 days 40mg/kg IV 8 hourly over 1 hour infusion 10 days Primary drug Inconvenience of frequent dosing requirement Pro-drug Considered more helpful (than acyclovir) in prevention of PHN Convenient dosing Pro-drug Contra-indicated for some patients Convenient dosing Pro-drug Only available for IV administration Reserved for cases resistant to acyclovir
nu607_case_study_herpes_zoster_in_patient_with_cll.docx